NDRG2 Contributes to Cisplatin Sensitivity Through Modulation of BAK-to-Mcl-1 Ratio

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2018 Jan 20

PMID 29348517

Citations 6

Authors

Soojong Park

Sang-Seok Oh

Ki Won Lee

Yeon-Kyeong Lee

Nae Yu Kim

Joo Heon Kim

Jiyun Yoo

Kwang Dong Kim

Affiliations

Soon will be listed here.

Abstract

The downregulation of N-Myc downstream-regulated gene 2 (NDRG2) is known to be associated with the progression and poor prognosis of several cancers. Sensitivity to anti-cancer may be associated with a good prognosis in cancer patients, and NDRG2, which is induced by p53, sensitizes the cells to chemotherapy. However, the unique function of NDRG2 as an inducer of apoptosis under chemotreatment has not been sufficiently studied. In this study, we investigated the role of NDRG2 in chemo-sensitivity, focusing on cisplatin in U937 histiocytic lymphoma, which has the loss-of-functional mutation in p53. NDRG2 promoted the sensitivity to cisplatin through the modulation of the BAK-to-Mcl-1 ratio. The degradation of Mcl-1 and increase in BAK were mediated by JNK activation and the eIF2α/p-eIF2α pathway, respectively, which depended on PKR activation in NDRG2-overexpressed U937 (U937-NDRG2) cells. NOX5 was highly expressed in U937-NDRG2 cells and contributed to ROS production after cisplatin treatment. ROS scavenging or NOX5-knockdown successfully inhibited the sensitivity of U937-NDRG2 cells to cisplatin. Taken together, these findings indicate that NDRG2 contributed to the increased sensitivity to ciplatin through the modulation of Bak-to-Mcl-1 ratio regulated by NOX5-ROS-PKR pathway; therefore, we suggest that NDRG2 may be a molecular target for improving the efficacy of drug treatment in cancer patients.

Citing Articles

The delivery of N-myc downstream-regulated gene 2 (NDRG2) self-amplifying mRNA via modified lipid nanoparticles as a potential treatment for drug-resistant and metastatic cancers.

Reznik S, Tiwari A, Chavda V, Ashby Jr C Med Rev (2021). 2024; 4(3):235-238.

PMID: 38919399 PMC: 11195423. DOI: 10.1515/mr-2024-0004.

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer.

Wu S, Zhao Q, Liu S, Kuang J, Zhang J, Onga A Int J Oncol. 2024; 65(2).

PMID: 38873997 PMC: 11251743. DOI: 10.3892/ijo.2024.5665.

Non-coding RNA and Drug resistance in cholangiocarcinoma.

Wu Z, Jiang S, Chen Y Noncoding RNA Res. 2023; 9(1):194-202.

PMID: 38125756 PMC: 10730441. DOI: 10.1016/j.ncrna.2023.11.003.

N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor.

Kim G, Lim S, Kim K Cells. 2021; 10(10).

PMID: 34685629 PMC: 8534062. DOI: 10.3390/cells10102649.

NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.

Kang F, Wang Y, Luo Y, Zhang Y J Ovarian Res. 2020; 13(1):48.

PMID: 32345304 PMC: 7189606. DOI: 10.1186/s13048-020-00649-0.

References

Lassegue B, San Martin A, Griendling K . Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012; 110(10):1364-90. PMC: 3365576. DOI: 10.1161/CIRCRESAHA.111.243972. View

Patel R, Sen G . Characterization of the interactions between double-stranded RNA and the double-stranded RNA binding domain of the interferon induced protein kinase. Cell Mol Biol Res. 1994; 40(7-8):671-82. View

Angel Garcia M, Carrasco E, Aguilera M, Alvarez P, Rivas C, Campos J . The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells. PLoS One. 2011; 6(8):e23887. PMC: 3161074. DOI: 10.1371/journal.pone.0023887. View

Andre N, De Lucca F . Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB. Cancer Lett. 2007; 258(1):118-25. DOI: 10.1016/j.canlet.2007.08.021. View

Yoon C, Lee E, Lim D, Bae Y . PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc Natl Acad Sci U S A. 2009; 106(19):7852-7. PMC: 2683089. DOI: 10.1073/pnas.0812148106. View

Angel Garcia M, Guerra S, Gil J, Jimenez V, Esteban M . Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene. 2002; 21(55):8379-87. DOI: 10.1038/sj.onc.1206036. View

Ichikawa T, Nakahata S, Fujii M, Iha H, Morishita K . Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development. Sci Rep. 2015; 5:12841. PMC: 4534796. DOI: 10.1038/srep12841. View

Inoshita S, Takeda K, Hatai T, Terada Y, Sano M, Hata J . Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J Biol Chem. 2002; 277(46):43730-4. DOI: 10.1074/jbc.M207951200. View

Wang S, Chen N, Dong N, Lu L, Liu L, Zhang L . Adenovirus siMDM2 and NDRG2 Gene Therapy Inhibits Cell Proliferation and Induces Apoptosis of Squamous Cell Carcinoma. Cell Biochem Biophys. 2016; 73(2):513-518. DOI: 10.1007/s12013-015-0691-8. View

10.

Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T . Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000; 288(5468):1053-8. DOI: 10.1126/science.288.5468.1053. View

11.

Peidis P, Papadakis A, Muaddi H, Richard S, Koromilas A . Doxorubicin bypasses the cytoprotective effects of eIF2α phosphorylation and promotes PKR-mediated cell death. Cell Death Differ. 2010; 18(1):145-54. PMC: 3131862. DOI: 10.1038/cdd.2010.76. View

12.

Oh S, Kim D, Kim D, Chang H, Sohn K, Kim K . NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production. Carcinogenesis. 2012; 33(10):1882-8. DOI: 10.1093/carcin/bgs211. View

13.

Kim H, Kim M, Lim J, Yang Y, Lee M, Lim J . NDRG2 overexpression enhances glucose deprivation-mediated apoptosis in breast cancer cells via inhibition of the LKB1-AMPK pathway. Genes Cancer. 2014; 5(5-6):175-85. PMC: 4104758. DOI: 10.18632/genesandcancer.17. View

14.

Wei Y, Yu S, Zhang Y, Zhang Y, Zhao H, Xiao Z . NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer. Oncotarget. 2017; 8(17):29038-29047. PMC: 5438710. DOI: 10.18632/oncotarget.16035. View

15.

Hiasa Y, Kamegaya Y, Nuriya H, Onji M, Kohara M, Schmidt E . Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol. 2003; 98(11):2528-34. DOI: 10.1111/j.1572-0241.2003.08663.x. View

16.

Cao W, Zhang J, Feng D, Liu X, Li Y, Wang L . The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity. Biomaterials. 2014; 35(3):993-1003. DOI: 10.1016/j.biomaterials.2013.09.096. View

17.

Marchal J, Lopez G, Peran M, Comino A, Delgado J, Garcia-Garcia J . The impact of PKR activation: from neurodegeneration to cancer. FASEB J. 2014; 28(5):1965-74. DOI: 10.1096/fj.13-248294. View

18.

Yu J, Zhang L, Hwang P, Kinzler K, Vogelstein B . PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell. 2001; 7(3):673-82. DOI: 10.1016/s1097-2765(01)00213-1. View

19.

Holterman C, Thibodeau J, Towaij C, Gutsol A, Montezano A, Parks R . Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. J Am Soc Nephrol. 2013; 25(4):784-97. PMC: 3968494. DOI: 10.1681/ASN.2013040371. View

20.

Manea A, Manea S, Gan A, Constantin A, Fenyo I, Raicu M . Human monocytes and macrophages express NADPH oxidase 5; a potential source of reactive oxygen species in atherosclerosis. Biochem Biophys Res Commun. 2015; 461(1):172-9. DOI: 10.1016/j.bbrc.2015.04.021. View